A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
CANNAPHARMARX, INC.
CPMD
$892K
Mkt Cap
$0.00
-14.29%
CANNAPHARMARX, INC. (CPMD) has a 5-year average return on invested capital (ROIC) of -64.6%. This is below average and may indicate limited pricing power.
CANNAPHARMARX, INC. (CPMD) has a market capitalization of $1M. It is classified as a small-cap stock.
CANNAPHARMARX, INC. (CPMD) does not currently pay a regular dividend.
CANNAPHARMARX, INC. (CPMD) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
CANNAPHARMARX, INC. (CPMD) generated $-2 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
CANNAPHARMARX, INC. (CPMD) reported earnings per share (EPS) of $-0.02 in its most recent fiscal year.
The Ledger Terminal provides 12 years of financial data for CANNAPHARMARX, INC. (CPMD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Description of current business CannaPharmaRx, Inc. (“CPMD”, “we”, “our”, or the “Company”) specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canada. Originally incorporated in the state of Colorado in August 1998 as Network Acquisitions, Inc., we evolved to focus on producing high-quality medical cannabis and craft products. Our principal executive office is located at 302, 3204—Rideau Place SW., Calgary, Alberta, Canada T2S 1Z2. On January 6, 2022, we entered into a 20-year operating lease for the use of a 55,000 square foot facility located in Cremona, Alberta, Canada (the “Facility”). During 2022, we recommissioned the Facility into a new indoor cannabis farm with 11 growing rooms and one (1) drying and packing room.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 1.7M | - | 0 | 0 | 0 | 0 |
| Net Income | -7.3M | -9.9M | 3.7M | -8.5M | -8.8M | -20M |
| EPS | $-0.02 | $-0.02 | $0.01 | $-0.04 | $-0.03 | $-0.49 |
| Free Cash Flow | 0 | -1.7M | -2.4M | -1.6M | -2.4M | -564K |
| ROIC | -27.0% | -33.3% | -13.5% | -65.0% | -68.2% | -143.3% |
| Gross Margin | -190.8% | - | - | - | - | - |
| Debt/Equity | 0.00 | -0.40 | -0.40 | -0.89 | -1.27 | -1.98 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -4.0M | -3.6M | -1.6M | -5.2M | -3.0M | -14M |
| Operating Margin | -233.1% | - | - | - | - | - |
| ROE | 0.0% | - | - | - | - | - |
| Shares Outstanding | 663M | 495M | 369M | 663M | 299M | 167M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | 1.7M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -190.8% |
| R&D | N/A | 324K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 267K | 1.1M | 4.2M | 277K | 7K | 9K | 478K | 2.1M | 853K | 2.2M | 704K | 117K | 123K |
| EBIT | -267K | -4.0M | -12M | -1.0M | -7K | -954K | -16M | -14M | -3.0M | -5.2M | -1.6M | -3.6M | -4.0M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -233.1% |
| Net Income | -292K | -4.0M | -12M | -1.0M | -7K | -3.1M | -20M | -20M | -8.8M | -8.5M | 3.7M | -9.9M | -7.3M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -429.3% |
| Non-Recurring | 0 | 0 | -88K | 0 | 0 | 0 | 7.1M | 8.0M | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | N/M | -174.7% | N/M | N/M | N/A | -21.3% | -197.5% | -143.3% | -68.2% | -65.0% | -13.5% | -33.3% | -27.0% |
| ROE | N/A | N/A | N/A | N/A | N/A | N/A | -421.3% | N/A | N/A | N/A | N/A | N/A | 0.0% |
| ROA | -1168536.0% | -442.8% | -1298.2% | -14589.1% | N/A | -30.6% | -127.7% | -227.4% | -7725.4% | -134.6% | 31.4% | -87.7% | -63.0% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -34K | -1.5M | -2.5M | -22K | 0 | -941K | -3.8M | -564K | -2.4M | -1.4M | -2.3M | -1.7M | -2.0M |
| Free Cash Flow | -34K | -1.6M | -2.6M | -22K | 0 | -941K | -3.8M | -564K | -2.4M | -1.6M | -2.4M | -1.7M | 0 |
| Owner Earnings | -109K | -2.1M | -10.0M | -751K | 0 | -970K | -4.7M | -1.5M | -2.8M | -1.9M | -2.4M | -1.7M | -1.9M |
| CapEx | 0 | 101K | 2K | 0 | 0 | 0 | 5K | 0 | 6K | 116K | 81K | 0 | 0 |
| Maint. CapEx | 0 | 3K | 15K | 0 | 0 | 0 | 129K | 129K | 3K | 295K | 128K | 0 | -87K |
| Growth CapEx | N/A | 98K | 0 | N/A | N/A | N/A | 0 | N/A | 4K | 0 | 0 | N/A | 87K |
| D&A | 0 | 3K | 15K | 0 | 0 | 0 | 129K | 129K | 3K | 295K | 128K | 0 | -87K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 99K | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | 0.3% | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 75K | 580K | 7.4M | 728K | 0 | 28K | 736K | 820K | 363K | 181K | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 705K | 54K | 54K | 0 | 88K | 88K |
| Balance Sheet | |||||||||||||
| Net Debt | 214K | N/A | N/A | 20K | 0 | 3.8M | 11M | 17M | 16M | 15M | 336K | 3.5M | -3.0M |
| Cash & Equiv. | 0 | 1.6M | 3K | 0 | 0 | 464K | 2K | 335K | 28K | 2K | 0 | 2K | 4.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | 2.1M | 5.5M | N/A | N/A | N/A | 3.3M | 6.7M | 479K |
| Debt/Equity | -0.73 | -7.23 | -1.02 | -0.02 | 0.00 | -14.96 | 2.29 | -1.98 | -1.27 | -0.89 | -0.40 | -0.40 | 0.00 |
| Interest Coverage | N/A | -787.3 | -4277.7 | -2375.6 | N/A | -0.4 | -3.6 | -6.3 | -2.0 | -2.3 | -0.9 | -1.6 | -1.6 |
| Equity | -292K | -288K | -685K | -958K | -964K | -286K | 4.9M | -8.8M | -13M | -17M | -12M | -20M | -23M |
| Total Assets | 0 | 1.8M | 12K | 2K | 0 | 10M | 16M | 8.7M | 114K | 6.3M | 12M | 11M | 12M |
| Total Liabilities | 292K | 2.1M | 697K | 959K | 964K | 10M | 11M | 18M | 13M | 24M | 24M | 31M | 34M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | 1.8M | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -17M | -21M | -33M | -34M | -34M | -37M | -57M | -77M | -86M | -95M | -91M | -101M | -105M |
| Working Capital | -292K | -291K | -685K | -958K | N/A | -3.2M | -3.7M | -17M | -13M | -18M | -18M | -25M | -27M |
| Current Assets | 0 | 1.6M | 12K | 2K | 0 | 599K | 1.9M | 468K | 30K | 100K | 1.2M | 1.0M | 1.5M |
| Current Liabilities | 292K | 1.9M | 697K | 959K | 964K | 3.8M | 5.7M | 18M | 13M | 18M | 19M | 26M | 28M |
| Per Share Data | |||||||||||||
| EPS | -0.04 | -0.36 | -0.77 | -0.06 | 0.00 | -0.17 | -0.66 | -0.49 | -0.03 | -0.04 | 0.01 | -0.02 | -0.02 |
| Owner EPS | -0.05 | -0.19 | -0.66 | -0.04 | 0.00 | -0.05 | -0.15 | -0.01 | -0.01 | -0.00 | -0.01 | -0.00 | -0.00 |
| Book Value | -0.12 | -0.03 | -0.04 | -0.06 | -0.05 | -0.02 | 0.16 | -0.05 | -0.04 | -0.03 | -0.03 | -0.04 | -0.03 |
| Cash Flow/Share | -0.01 | -0.14 | -0.17 | -0.00 | 0.00 | -0.05 | -0.12 | -0.00 | -0.01 | -0.00 | -0.01 | -0.00 | -0.01 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 2.4M | 11.1M | 15.3M | 16.7M | 18.0M | 18.2M | 31.0M | 166.6M | 299.0M | 662.5M | 368.8M | 495.3M | 662.5M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.1 | N/A | -0.1 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | 7.7 | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.7 |
| FCF Yield | -1.6% | -5.4% | -9.6% | -0.3% | N/A | -3.0% | -10.2% | -0.7% | -57.8% | -75.5% | -580.5% | -45.7% | N/A |
| Market Cap | 2.1M | 30M | 27M | 6.7M | 14M | 31M | 37M | 82M | 4.2M | 2.1M | 406K | 3.7M | 1.2M |
| Avg. Price | 0.11 | 1.59 | 2.54 | 0.60 | 0.38 | 1.19 | 1.85 | 0.95 | 0.15 | 0.01 | 0.01 | 0.01 | 0.00 |
| Year-End Price | 0.12 | 2.75 | 1.75 | 0.40 | 0.53 | 1.70 | 1.20 | 0.50 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 |
CANNAPHARMARX, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
CANNAPHARMARX, INC. (CPMD) has a book value per share of $-0.04, based on its most recent annual SEC filing.
No recent press releases.